semaglutide for obesity 50 mg of oral #semaglutide daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj Semaglutide GLP-1 Injections for Weight
Description
Cureus, 18(1), e101693
Here's the problem:
Retatrutide belongs to the class of drugs known as glucagon-like peptide-1 (GLP-1) agonists, much like Wegovy and Ozempic
Canada added the cardiovascular label in 2024, and provincial formularies followed by mid-2025, expanding patient eligibility
doi: 10.4158/EP.12.4.358
Mosenzon O, Blicher TM, Rosenlund S, Eriksson JW, Heller S, Hels OH, Pratley R, Sathyapalan T, Desouza C
